Pet Calming Products Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

The pet calming products market encompasses a range of non-prescription and prescription items designed to reduce stress and anxiety in companion animals, primarily dogs and cats. Products include food supplements, treats, gels, sprays, and topical ointments, often formulated with natural ingredients like chamomile, L-theanine, and CBD derivatives.

• •The market reached $1.724 billion in 2026, up from $1.55 billion in 2025, reflecting strong consumer adoption.
• •Demand is concentrated in dogs and cats, which together account for over 90% of product usage globally.
• •Product formats are evolving toward palatable, easy-to-administer forms like treats and sprays to improve compliance.

Rising pet humanization trends and increased spending on pet mental health are primary growth catalysts. Pet owners are more willing to invest in behavioral wellness, especially as urbanization and lifestyle changes contribute to higher stress levels in companion animals.

• •Growing prevalence of separation anxiety and noise phobias in pets is driving demand for targeted calming solutions.
• •Increased availability of vet-recommended and clinically tested products is boosting consumer trust.
• •Rising disposable incomes in emerging economies are expanding the customer base beyond traditional markets.

The market is segmented by pet type, product form, ingredient composition, and distribution channel, with North America and Europe leading in consumption due to higher pet ownership rates and regulatory clarity. Asia-Pacific is the fastest-growing region, fueled by urbanization and rising middle-class spending.

• •Food & supplements and snacks & treats represent the largest product segments by revenue, favored for daily use.
• •Online retail channels are growing faster than brick-and-mortar due to convenience and product variety.
• •North America holds the largest market share, while Asia-Pacific is projected to register the highest CAGR through 2031.

Who are the notable companies in the industry?

The market is moderately fragmented, with a mix of integrated pet care conglomerates and specialized producers focusing on natural or veterinary-grade formulations. Production relies primarily on botanical extraction, encapsulation, and emulsion technologies, with supply chains concentrated in North America, Western Europe, and East Asia due to regulatory infrastructure and ingredient sourcing capabilities.

• •The industry features a balance between large diversified players and niche specialty brands, with no single entity dominating.
• •Most producers integrate formulation, manufacturing, and packaging in-house, though some outsource raw material sourcing.
• •Regional manufacturing capacity is concentrated in North America and Europe for quality control, with growing production in China and India to serve local demand.

What are the recent trends and outlook?

Future growth will be shaped by innovation in delivery systems, increased use of science-backed ingredients, and regulatory harmonization across regions. The market is expected to surpass $3 billion by 2031, with premiumization and subscription-based models gaining traction among pet owners.

• •CBD and adaptogenic botanicals are increasingly replacing synthetic sedatives in over-the-counter products.
• •Smart packaging with dosage tracking and QR-linked usage guides is emerging as a differentiator.
• •Regulatory scrutiny on ingredient claims is intensifying, pushing manufacturers toward clinical validation and transparency.